Search Results - "Loonen, A."

Refine Results
  1. 1

    An evaluation of three processing methods and the effect of reduced culture times for faster direct identification of pathogens from BacT/ALERT blood cultures by MALDI-TOF MS by Loonen, A. J. M., Jansz, A. R., Stalpers, J., Wolffs, P. F. G., van den Brule, A. J. C.

    “…Matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS) is a fast and reliable method for the identification of bacteria…”
    Get full text
    Journal Article
  2. 2

    Developments for improved diagnosis of bacterial bloodstream infections by Loonen, A. J. M., Wolffs, P. F. G., Bruggeman, C. A., van den Brule, A. J. C.

    “…Bloodstream infections (BSIs) are associated with high mortality and increased healthcare costs. Optimal management of BSI depends on several factors including…”
    Get full text
    Journal Article
  3. 3

    Circuits regulating pleasure and happiness in major depression by Loonen, A.J.M, Ivanova, S.A

    Published in Medical hypotheses (01-02-2016)
    “…Abstract The introduction of selective serotonin reuptake inhibitors has gradually changed the borders of the major depression disease class. Anhedonia was…”
    Get full text
    Journal Article
  4. 4

    High pneumococcal DNA load, procalcitonin and suPAR levels correlate to severe disease development in patients with pneumococcal pneumonia by Loonen, A. J. M., Kesarsing, C., Kusters, R., Hilbink, M., Wever, P. C., van den Brule, A. J. C.

    “…Community-acquired pneumonia (CAP) is mostly caused by Streptococcus pneumoniae . Identification of the pathogen causing CAP can be achieved by conventional…”
    Get full text
    Journal Article
  5. 5

    Treatment adherence therapy in people with psychotic disorders: randomised controlled trial by Staring, A. B. P., Van der Gaag, M., Koopmans, G. T., Selten, J. P., Van Beveren, J. M., Hengeveld, M. W., Loonen, A. J. M., Mulder, C. L.

    Published in British journal of psychiatry (01-12-2010)
    “…Interventions to improve adherence to treatment in people with psychotic disorders have produced inconclusive results. We developed a new treatment, treatment…”
    Get full text
    Journal Article
  6. 6

    Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia by GOEMANS, B. F, ZWAAN, Ch. M, KASPERS, G. J. L, HEINRICH, M. C, MILLER, M, ZIMMERMANN, M, HARLOW, A, MESHINCHI, S, LOONEN, A. H, HIHLEN, K, REINHARDT, D, CREUTZIG, U

    Published in Leukemia (01-09-2005)
    “…Activating mutations in RAS and receptor tyrosine kinases such as KIT and FLT3 are hypothesized to cooperate with chimeric transcription factors in the…”
    Get full text
    Journal Article
  7. 7

    Exploring the paradigm of depressive disorders through an evolutionary and biopsychosocial lens by Ochi, T, Loonen, A J, Simutkin, G G, Bokhan, N A, Kornetov, A N, Ivanova, S A

    Published in European psychiatry (01-03-2023)
    “…IntroductionDepression can be considered to be a common psychological response to adversity or loss from which an individual may recover quickly based on a…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Practical recommendations for improvement of the physical health care of patients with severe mental illness by van Hasselt, F. M., Oud, M. J. T., Loonen, A. J. M.

    Published in Acta psychiatrica Scandinavica (01-05-2015)
    “…Objective Health care for the physical health of patients with severe mental illness (SMI) needs to be improved. Therefore, we aimed to develop policy…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Evaluating interventions to improve somatic health in severe mental illness: a systematic review by van Hasselt, F. M., Krabbe, P. F. M., van Ittersum, D. G., Postma, M. J., Loonen, A. J. M.

    Published in Acta psychiatrica Scandinavica (01-10-2013)
    “…Objective To present a systematic review of the evaluation of randomized interventions directed toward improving somatic health for patients with severe mental…”
    Get full text
    Journal Article
  12. 12
  13. 13

    NMDA receptor genotypes associated with the vulnerability to develop dyskinesia by Ivanova, S A, Loonen, A J M, Pechlivanoglou, P, Freidin, M B, Al Hadithy, A F Y, Rudikov, E V, Zhukova, I A, Govorin, N V, Sorokina, V A, Fedorenko, O Y, Alifirova, V M, Semke, A V, Brouwers, J R B J, Wilffert, B

    Published in Translational psychiatry (01-01-2012)
    “…Dyskinesias are involuntary muscle movements that occur spontaneously in Huntington's disease (HD) and after long-term treatments for Parkinson's disease…”
    Get full text
    Journal Article
  14. 14

    Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia by Al Hadithy, A.F.Y., Ivanova, S.A., Pechlivanoglou, P., Semke, A., Fedorenko, O., Kornetova, E., Ryadovaya, L., Brouwers, J.R.B.J., Wilffert, B., Bruggeman, R., Loonen, A.J.M.

    “…Pharmacogenetics of tardive dyskinesia and dopamine D3 (DRD3), serotonin 2A (HTR2A), and 2C (HTR2C) receptors has been examined in various populations, but not…”
    Get full text
    Journal Article
  15. 15

    Influencing CYP enzymes to boost psychiatric treatment: a review on clinical evidence by van Hasselt, F M, Coehorst, Y, Wilffert, B, Loonen, A J M

    Published in Pharmacopsychiatry (01-03-2013)
    “…Therapeutic drug monitoring to optimize blood plasma concentrations is advised for certain psychiatric drugs. The current standard is to change the dose based…”
    Get more information
    Journal Article
  16. 16

    Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia by Al Hadithy, A. F. Y., Ivanova, S. A., Pechlivanoglou, P., Wilffert, B., Semke, A., Fedorenko, O., Kornetova, E., Ryadovaya, L., Brouwers, J. R. B. J., Loonen, A. J. M.

    Published in Human psychopharmacology (01-01-2010)
    “…Neuronal degeneration due to oxidative stress (OS) has been proposed as a mechanism for tardive dyskinesia (TD) pathogenesis. Cellular defense mechanisms…”
    Get full text
    Journal Article
  17. 17

    EPA-0301 – Improving somatic health of outpatients with severe mental illness by Van Hasselt, F, Oud, M, Krabbe, P, Postma, M, Loonen, A

    Published in European psychiatry (2014)
    “…Introduction Patients with severe mental illness (SMI) experience a 13- to 30-year reduction in life-expectancy. The majority of these deaths can be attributed…”
    Get full text
    Journal Article
  18. 18

    TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia by WOERDEN, N. L. R.-V, PIETERS, R, HÄHLEN, K, SCHMIEGELOW, K, JANKA-SCHAUB, G. E, VEERMAN, A. J. P, LOONEN, A. H, HUBEEK, I, VAN DRUNEN, E, BEVERLOO, H. B, SLATER, R. M, HARBOTT, J, SEYFARTH, J, VAN WERING, E. R

    Published in Blood (01-08-2000)
    “…The t(12;21) translocation resulting in TEL/AML1 gene fusion is present in approximately 25% of patients with precursor B-lineage pediatric acute lymphoblastic…”
    Get full text
    Journal Article
  19. 19

    Skin disorders in chronic psychiatric illness by Mookhoek, EJ, Van De Kerkhof, PCM, Hovens, JEJM, Brouwers, JRBJ, Loonen, AJM

    “…Background  Chronic psychiatric patients are prone to develop skin diseases. However, epidemiological data are scarce. Objective  To describe the prevalence of…”
    Get full text
    Journal Article
  20. 20